{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:59:29Z","timestamp":1761505169732,"version":"build-2065373602"},"reference-count":63,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lung-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lung Cancer"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.cllc.2012.03.006","type":"journal-article","created":{"date-parts":[[2012,6,2]],"date-time":"2012-06-02T04:46:20Z","timestamp":1338612380000},"page":"416-423","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Role of Hormone Receptor Expression in Patients With Advanced-Stage Lung Cancer Treated With Chemotherapy"],"prefix":"10.1016","volume":"13","author":[{"given":"Valentina","family":"Monica","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Longo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Felice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio V.","family":"Scagliotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Papotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Novello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cllc.2012.03.006_bib1","first-page":"5","article-title":"Cancer statistics","author":"Jemal","year":"2003","journal-title":"CA Cancer J Clin 2003"},{"key":"10.1016\/j.cllc.2012.03.006_bib2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.athoracsur.2003.11.021","article-title":"Gender differences in non-small-cell lung cancer survival: an analysis of 4,618 patients diagnosed between 1997 and 2002","volume":"78","author":"Visbal","year":"2004","journal-title":"Ann Thorac Surg"},{"article-title":"IAfRoC","year":"2003","series-title":"World Cancer Report","key":"10.1016\/j.cllc.2012.03.006_bib3"},{"key":"10.1016\/j.cllc.2012.03.006_bib4","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/jnci\/88.3-4.183","article-title":"Differences in lung cancer risk between men and women: examination of the evidence","volume":"88","author":"Zang","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.cllc.2012.03.006_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lungcan.2003.08.024","article-title":"Women's susceptibility to tobacco carcinogens","volume":"43","author":"Henschke","year":"2004","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cllc.2012.03.006_bib6","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/oxfordjournals.aje.a116857","article-title":"Are female smokers at higher risk for lung cancer than male smokers?","volume":"138","author":"Risch","year":"1993","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.cllc.2012.03.006_bib7","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1093\/annonc\/mdf187","article-title":"Lung cancer in women: age, smoking, histology, performance status, stage, initial treatment and survival","volume":"13","author":"Radzikowska","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1016\/j.cllc.2012.03.006_bib8","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1200\/JCO.2006.07.2983","article-title":"Lung cancer incidence in never smokers","volume":"25","author":"Wakelee","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cllc.2012.03.006_bib9","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S1470-2045(01)00457-0","article-title":"Women and lung cancer: does oestrogen play a role?","volume":"2","author":"Siegfried","year":"2001","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.cllc.2012.03.006_bib10","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1001\/jama.291.14.1763","article-title":"Lung cancer in US women: a contemporary epidemic","volume":"291","author":"Patel","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.cllc.2012.03.006_bib11","doi-asserted-by":"crossref","first-page":"8542","DOI":"10.1128\/MCB.23.23.8542-8552.2003","article-title":"Regulation of postnatal lung development and homeostasis by estrogen receptor beta","volume":"23","author":"Patrone","year":"2003","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.cllc.2012.03.006_bib12","first-page":"2141","article-title":"Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptor alpha and beta and show biological responses to estrogen","volume":"62","author":"Stabile","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.cllc.2012.03.006_bib13","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.steroids.2005.02.017","article-title":"Estrogen and growth factor receptor interactions in human breast and non-small cell lung cancer cells","volume":"70","author":"Pietras","year":"2005","journal-title":"Steroids"},{"key":"10.1016\/j.cllc.2012.03.006_bib14","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.steroids.2006.11.019","article-title":"Estrogen receptor signaling pathways in human non-small cell lung cancer","volume":"72","author":"M\u00e1rquez-Garb\u00e1n","year":"2007","journal-title":"Steroids"},{"key":"10.1016\/j.cllc.2012.03.006_bib15","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0169-5002(02)00039-9","article-title":"Expression of estrogen receptors alpha and beta in human lung tissue and cell lines","volume":"37","author":"Mollerup","year":"2002","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cllc.2012.03.006_bib16","first-page":"4206","article-title":"Steroid receptors in human lung cancer","volume":"45","author":"Beattie","year":"1985","journal-title":"Cancer Res"},{"key":"10.1016\/j.cllc.2012.03.006_bib17","first-page":"4258","article-title":"Human estrogen receptor beta-gene structure, chromosomal localization, and expression pattern","volume":"82","author":"Enmark","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cllc.2012.03.006_bib18","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.jtcvs.2005.06.012","article-title":"The significance of estrogen receptor beta in 301 surgically treated non-small cell lung cancers","volume":"130","author":"Wu","year":"2005","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cllc.2012.03.006_bib19","doi-asserted-by":"crossref","first-page":"7280","DOI":"10.1158\/1078-0432.CCR-05-0498","article-title":"Nuclear estrogen receptor beta in lung cancer: expression and survival differences by sex","volume":"11","author":"Schwartz","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cllc.2012.03.006_bib20","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.lungcan.2007.07.025","article-title":"Oestrogen receptor beta over expression in males with non-small cell lung cancer is associated with better survival","volume":"59","author":"Skov","year":"2008","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cllc.2012.03.006_bib21","first-page":"4693","article-title":"Combined overexpression of EGFR and estrogen receptor alpha correlates with a poor outcome in lung cancer","volume":"25","author":"Kawai","year":"2005","journal-title":"Anticancer Res"},{"key":"10.1016\/j.cllc.2012.03.006_bib22","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1158\/0008-5472.CAN-04-2694","article-title":"Regulation of endogenous gene expression in human non-small cell lung cancer cells by estrogen receptor ligands","volume":"65","author":"Hershberger","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.cllc.2012.03.006_bib23","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.1158\/1078-0432.CCR-07-1950","article-title":"Intratumoral estrogens and estrogen receptors in human non-small cell lung carcinoma","volume":"14","author":"Niikawa","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cllc.2012.03.006_bib24","first-page":"342","article-title":"Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis","volume":"15","author":"Simpson","year":"1994","journal-title":"Endocr Rev"},{"key":"10.1016\/j.cllc.2012.03.006_bib25","doi-asserted-by":"crossref","first-page":"10484","DOI":"10.1158\/0008-5472.CAN-07-2607","article-title":"Aromatase expression predicts survival in women with early-stage non small cell lung cancer","volume":"67","author":"Mah","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.cllc.2012.03.006_bib26","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1056\/NEJMoa011954","article-title":"Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer","volume":"346","author":"Schiller","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cllc.2012.03.006_bib27","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1158\/0008-5472.CAN-08-2981","article-title":"Non-small cell lung cancer exhibits transcript overexpression of genes associated with homologous recombination and DNA replication pathways","volume":"69","author":"Saviozzi","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.cllc.2012.03.006_bib28","first-page":"689","article-title":"Genetic susceptibility to lung cancer: the role of DNA damage and repair","volume":"12","author":"Spitz","year":"2003","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.cllc.2012.03.006_bib29","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/jnci\/94.14.1091","article-title":"An analysis of DNA repair as a determinant of survival in patients with non-small-cell lung cancer","volume":"94","author":"Bosken","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.cllc.2012.03.006_bib30","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJMoa060570","article-title":"DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy","volume":"355","author":"Olaussen","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cllc.2012.03.006_bib31","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1056\/NEJMc072007","article-title":"ERCC1-specific immunostaining in non-small-cell lung cancer","volume":"357","author":"Olaussen","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cllc.2012.03.006_bib32","first-page":"2286","article-title":"Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer","volume":"8","author":"Lord","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cllc.2012.03.006_bib33","doi-asserted-by":"crossref","first-page":"4254","DOI":"10.1200\/JCO.2008.18.8631","article-title":"Different impact of excision repair cross-complementation group 1 on survival in male and female patients with inoperable non-small-cell lung cancer treated with carboplatin and gemcitabine","volume":"27","author":"Holm","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cllc.2012.03.006_bib34","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1093\/annonc\/mdl300","article-title":"ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabine","volume":"17","author":"Ceppi","year":"2006","journal-title":"Ann Oncol"},{"issue":"suppl","key":"10.1016\/j.cllc.2012.03.006_bib35","first-page":"15s","article-title":"Histology- and gender- related association of ERCC1, RRM1 and TS biomarkers in 1802","volume":"28","author":"Gandara","year":"2010","journal-title":"J Clin Oncol"},{"issue":"suppl","key":"10.1016\/j.cllc.2012.03.006_bib36","article-title":"Gender differences in the predictive power of prognostic factors in NSCLC","volume":"23","author":"Danenberg","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cllc.2012.03.006_bib37","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/JTO.0b013e3181c0a602","article-title":"Correlation between epidermal growth factor receptor mutations and expression of female hormone receptors in East-Asian lung adenocarcinomas","volume":"5","author":"Toh","year":"2010","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.cllc.2012.03.006_bib38","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1479-5876-8-135","article-title":"Detection of EGFR mutations with mutation-specific antibodies in stage IV non-small-cell lung cancer","volume":"8","author":"Simonetti","year":"2010","journal-title":"J Transl Med"},{"key":"10.1016\/j.cllc.2012.03.006_bib39","first-page":"435","volume":"Vol 2002","author":"Greene","year":"2002"},{"key":"10.1016\/j.cllc.2012.03.006_bib40","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1053\/j.seminoncol.2009.10.001","article-title":"Lung cancer outcomes in women","volume":"36","author":"Shafer","year":"2009","journal-title":"Semin Oncol"},{"key":"10.1016\/j.cllc.2012.03.006_bib41","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1749-6632.2009.04116.x","article-title":"Targeting aromatase and estrogen signaling in human non-small cell lung cancer","volume":"1155","author":"M\u00e1rquez-Garb\u00e1n","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.cllc.2012.03.006_bib42","doi-asserted-by":"crossref","first-page":"11287","DOI":"10.1158\/0008-5472.CAN-05-2737","article-title":"Aromatase inhibitors in human lung cancer therapy","volume":"65","author":"Weinberg","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.cllc.2012.03.006_bib43","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/(SICI)1097-0215(19960729)67:3<357::AID-IJC9>3.0.CO;2-Q","article-title":"Steroid-hormone receptors in cell lines and tumor biopsies of human lung cancer","volume":"67","author":"Kaiser","year":"1996","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cllc.2012.03.006_bib44","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.mce.2011.02.018","article-title":"Suppression of estrogen actions in human lung cancer","volume":"340","author":"Miki","year":"2011","journal-title":"Mol Cell Endocrinol"},{"issue":"2","key":"10.1016\/j.cllc.2012.03.006_bib45","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.lungcan.2011.03.009","article-title":"Expression levels of estrogen receptor beta in conjunction with aromatase predict survival in non-small cell lung cancer","volume":"74","author":"Mah","year":"2011","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cllc.2012.03.006_bib46","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.5858\/2000-124-1467-EAPRIN","article-title":"Estrogen and progesterone receptors in non-small cell lung cancer in 248 consecutive patients who underwent surgical resection","volume":"124","author":"Di Nunno","year":"2000","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.cllc.2012.03.006_bib47","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/annonc\/mdh011","article-title":"Epidermal growth factor receptor overexpression correlates with a poor prognosis in completely resected non-small-cell lung cancer","volume":"15","author":"Selvaggi","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1016\/j.cllc.2012.03.006_bib48","first-page":"1850","article-title":"Epidermal growth factor receptor and HER2-neu mRNA expression in non-small cell lung cancer is correlated with survival","volume":"7","author":"Brabender","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cllc.2012.03.006_bib49","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1158\/1078-0432.CCR-0373-3","article-title":"Synchronous overexpression of epidermal growth factor receptor and HER2-neu protein is a predictor of poor outcome in patients with stage I non-small cell lung cancer","volume":"10","author":"Onn","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cllc.2012.03.006_bib50","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/01.JTO.0000268676.79872.9b","article-title":"EGFR and HER2 gene copy number and response to first-line chemotherapy in patients with advanced non-small cell lung cancer (NSCLC)","volume":"2","author":"Cappuzzo","year":"2007","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.cllc.2012.03.006_bib51","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1002\/1097-0142(19900501)65:9<1980::AID-CNCR2820650917>3.0.CO;2-U","article-title":"Relationship between epidermal growth factor receptor status and various prognostic factors in human breast cancer","volume":"65","author":"Toi","year":"1990","journal-title":"Cancer"},{"key":"10.1016\/j.cllc.2012.03.006_bib52","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/path.1370","article-title":"Expression of the HER1-4 family of receptor tyrosine kinases in breast cancer","volume":"200","author":"Witton","year":"2003","journal-title":"J Pathol"},{"key":"10.1016\/j.cllc.2012.03.006_bib53","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1158\/0008-5472.CAN-04-1872","article-title":"Combined targeting of the estrogen receptor and the epidermal growth factor receptor in non-small cell lung cancer shows enhanced antiproliferative effects","volume":"65","author":"Stabile","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.cllc.2012.03.006_bib54","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.lungcan.2008.07.002","article-title":"Pilot study of gefitinib and fulvestrant in the treatment of post-menopausal women with advanced non-small cell lung cancer","volume":"64","author":"Traynor","year":"2009","journal-title":"Lung Cancer"},{"issue":"suppl","key":"10.1016\/j.cllc.2012.03.006_bib55","first-page":"15s","article-title":"Phase II trial evaluating addition of fulvestrant to erlotinib in patients with stage IIIb\/IV non-small cell lung cancer (NSCLC) who are stable on erlotinib and exhibit immunohistochemical (IHC) or PCR positivity for estrogen or progesterone receptor (PR)","volume":"28","author":"Bazhenova","year":"2010","journal-title":"J Clin Oncol"},{"issue":"suppl","key":"10.1016\/j.cllc.2012.03.006_bib56","first-page":"15s","article-title":"Randomized phase II study of erlotinib (E) alone or combined with fulvestrant (F) in previously treated patients with advanced non-small cell lung cancer (NSCLC)","volume":"28","author":"Garon","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cllc.2012.03.006_bib57","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.lungcan.2008.02.021","article-title":"Expression of excision repair cross-complementation group 1 and class III beta-tubulin predict survival after chemotherapy for completely resected non-small cell lung cancer","volume":"62","author":"Okuda","year":"2008","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cllc.2012.03.006_bib58","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.lungcan.2007.08.025","article-title":"ERCC1 protein expression predicts the response of cisplatin-based neoadjuvant chemotherapy in non-small-cell lung cancer","volume":"59","author":"Fujii","year":"2008","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cllc.2012.03.006_bib59","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.lungcan.2008.03.010","article-title":"Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB\/IV non-small cell lung carcinoma \u2014 a randomized phase II trial","volume":"62","author":"Hsu","year":"2008","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cllc.2012.03.006_bib60","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.lungcan.2007.10.014","article-title":"ERCC1 expression by immunohistochemistry and EGFR mutations in resected non-small cell lung cancer","volume":"60","author":"Lee","year":"2008","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cllc.2012.03.006_bib61","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00280-008-0907-3","article-title":"Expression of ERCC1 and class III beta-tubulin in non-small cell lung cancer patients treated with a combination of cisplatin\/docetaxel and concurrent thoracic irradiation","volume":"64","author":"Azuma","year":"2009","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.cllc.2012.03.006_bib62","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1158\/1078-0432.CCR-08-1227","article-title":"Polymerase eta mRNA expression predicts survival of non-small cell lung cancer patients treated with platinum-based chemotherapy","volume":"15","author":"Ceppi","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cllc.2012.03.006_bib63","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1200\/JCO.2008.18.3251","article-title":"Association between estrogen receptor-beta expression and epidermal growth factor receptor mutation in the postoperative prognosis of adenocarcinoma of the lung","volume":"27","author":"Nose","year":"2009","journal-title":"J Clin Oncol"}],"container-title":["Clinical Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730412000733?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730412000733?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:55:23Z","timestamp":1761504923000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525730412000733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":63,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S1525730412000733"],"URL":"https:\/\/doi.org\/10.1016\/j.cllc.2012.03.006","relation":{},"ISSN":["1525-7304"],"issn-type":[{"type":"print","value":"1525-7304"}],"subject":[],"published":{"date-parts":[[2012,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of Hormone Receptor Expression in Patients With Advanced-Stage Lung Cancer Treated With Chemotherapy","name":"articletitle","label":"Article Title"},{"value":"Clinical Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cllc.2012.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}